Jean-Christophe Marine

This inventor holds 10 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignees: Katholieke Universiteit Leuven, Vib Vzw, Leiden University Medical Center. Active years: 2013-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jean-Christophe Marine. Retrieved from https://idiyas.com/inventor/jean-christophe-marine

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 4)

% Patents Active = 70.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 4 (Patent Applications = 6)

Average Co-Inventor Count = 2.5

ph-index = 2

Forward Citations = 31(Granted Patents)

Location History:

Erbisoeul, BE (2013 - 2016)
Brussels, BE (2017 - 2020)
Linden, BE (2021)

Company Filing History:

7 out of 631

Katholieke Universiteit Leuven

Leiden University Medical Center

patents

4. 3 out of 281

St. Jude Children's Research Hospital

Agency for Science, Technology and Research

patents

7. 2 out of 7

Flanders Interuniversity Institute for Biotechnology

patents

8. 1 out of 1

Vib Vzw and Universiteit Gent

patent

where one patent can have more than one assignee

Years Active: 2013-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12139712 - Direct and selective inhibition of MDM4 for treatment of cancer (2024-11-12),

2. RE48856 - Inhibition of NEAT1 for treatment of solid tumors (2021-12-20),

3. RE48801 - Inhibition of a lncRNA for treatment of melanoma (2021-11-01),

4. 10767182 - Direct and selective inhibition of MDM4 for treatment of cancer (2020-09-08),

5. 9821004 - Inhibition of a lncRNA for treatment of melanoma (2017-11-21),

6. 9783803 - Inhibition of NEAT1 for treatment of solid tumors (2017-10-10),

7. 9408885 - Combinations of therapeutic agents for treating melanoma (2016-08-09),

8. 9078895 - Method for treating ocular cancer (2015-07-14),

9. 8614192 - Method for treating ocular cancer (2013-12-24),

10. 8470785 - Method for treating ocular cancer (2013-06-25),

Title: Jean-Christophe Marine: Innovator from Erbisoeul

Introduction: Jean-Christophe Marine is a renowned inventor hailing from Erbisoeul, Belgium, known for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Jean-Christophe Marine holds several patents in the areas of robotics, artificial intelligence, and renewable energy, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Jean-Christophe Marine has worked with leading tech companies and research institutions, spearheading projects that have revolutionized various industries.

Collaborations: Throughout his career, Jean-Christophe Marine has collaborated with top engineers, scientists, and designers, fostering a culture of innovation and creativity that has led to the development of cutting-edge technologies.

Conclusion: Jean-Christophe Marine's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor, inspiring the next generation of innovators to push the boundaries of what is possible.

Profile summary based on public USPTO records.